PPAR-mediated activity of phthalates: A link to the obesity epidemic?

@article{Desvergne2009PPARmediatedAO,
  title={PPAR-mediated activity of phthalates: A link to the obesity epidemic?},
  author={B{\'e}atrice Desvergne and Jerome N. Feige and Cristina Casals-Casas},
  journal={Molecular and Cellular Endocrinology},
  year={2009},
  volume={304},
  pages={43-48}
}
The endocrine disruption hypothesis asserts that exposure to small amounts of some chemicals in the environment may interfere with the endocrine system and lead to harmful effects in wildlife and humans. Many of these chemicals may interact with members of the nuclear receptor superfamily. Peroxisome proliferator-activated receptors (PPARs) are such candidate members, which interact with many different endogenous and exogenous lipophilic compounds. More particularly, the roles of PPARs in lipid… 
Tributyltin is a potent inhibitor of piscine peroxisome proliferator-activated receptor α and β.
TLDR
A high-throughput assay to identify chemicals interacting with piscine peroxisome proliferator-activated receptors (PPARs) and tributyl tin oxide (TBTO) is reported, showing activity at environmentally relevant concentrations of TBTO (1-50 nM).
The endocrine disruptor mono-(2-ethylhexyl)phthalate promotes adipocyte differentiation and induces obesity in mice
TLDR
Perinatal exposure to MEHP may be expected to increase the incidence of obesity in a sex-dependent manner and can act as a potential chemical stressor for obesity and obesity-related disorders.
Minireview: PPARγ as the target of obesogens
The peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of adipogenesis and is medically important for its connections to obesity and the treatment of type II diabetes.
Reprint of “In silico methods in the discovery of endocrine disrupting chemicals”
TLDR
An overview of case studies and in silico methods that are used in the search of endocrine disrupting chemicals (EDCs) and their mechanism of action is provided.
In silico methods in the discovery of endocrine disrupting chemicals
TLDR
This review provides an overview of case studies and in silico methods that are used in the search of endocrine disruptors, and reports the identification of previously unknown 17β-HSD3 inhibitors, MR agonists, and ER antagonists/agonists.
Dichotomy of bisphenol A-induced expression of peroxisome proliferator-activated receptors in hepatic and testicular tissues in mice.
TLDR
The present study warrants exploration of the role of PPARs in BPA-induced effects on male reproductive functions and offers an insight into the peculiar response of BPA at low subchronic levels which may be helpful in designing appropriate risk assessment framework.
Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link?
TLDR
It is concluded that the pulmonary concentrations of some phthalates may be sufficient to cause a direct activation of PPARs, which is not a likely molecular mechanism for adverse effects of phthalate effects in the lung.
Phthalates efficiently bind to human peroxisome proliferator activated receptor and retinoid X receptor α, β, γ subtypes: an in silico approach
TLDR
An overview on the preference of phthalic acid esters, natural and synthetic ligands on to hPPAR and hRXR subtypes is given, which would lead to further in vitro mechanistic as well as in vivo preclinical and clinical studies.
Docking study: PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl) phthalate
TLDR
Dock phthalates in medical devices in order to identify compounds that are likely to interact with PPARs binding sites and the results obtained are generally very mixed on the harmlessness of these alternatives.
Associations of Phthalate Metabolites and Obesity-Related Metabolic Factors
TLDR
Current evidence on the potential hazards of phthalates with regard to metabolic disease is summarized and the importance of further investigation is highlighted that will have high public health significance for both developed as well as developing countries, where the exposure may continue to be high for decades to come.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Interference of pollutants with PPARs: endocrine disruption meets metabolism
TLDR
Evidence from mouse models suggests that in utero exposure to the phthalate ester di-ethyl-hexyl-phthalate most likely does not predispose to obesity, and a subclass of EDCs that perturb metabolic signaling is proposed to define as metabolic disruptors.
The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis*
TLDR
Structural and functional analyses are performed that demonstrate how monoethyl-hexyl-phthalate (MEHP) directly activates PPARγ and promotes adipogenesis, albeit to a lower extent than the full agonist rosiglitazone.
Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
TLDR
The preferential activation of PPARalpha by phthalate ester metabolites suggests that these phthalates mediate their toxic effects in rodent liver in a manner indistinguishable from other PP.
Activation of PPARα and PPARγ by Environmental Phthalate Monoesters
TLDR
The potential of environmental phthalate monoesters for activation of rodent and human PPARs is demonstrated and may help to elucidate the molecular basis for the adverse health effects proposed to be associated with humanphthalate exposure.
Activation of PPARalpha and PPARgamma by environmental phthalate monoesters.
  • C. H. Hurst, D. Waxman
  • Medicine
    Toxicological sciences : an official journal of the Society of Toxicology
  • 2003
TLDR
The potential of environmental phthalate monoesters for activation of rodent and human PPARs is demonstrated and may help to elucidate the molecular basis for the adverse health effects proposed to be associated with humanphthalate exposure.
Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
TLDR
The potency and efficacy of phthalate monoesters for the activation of PPARalpha and PPARgamma increase with increasing side-chain length, and it is shown that both mouse and human PPARGamma exhibit similar sensitivity to phthalates.
Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.
TLDR
TBT represents, to the authors' knowledge, the first example of an environmental endocrine disrupter that promotes adipogenesis through RXR and PPARgamma activation and may act as a chemical stressor for obesity and related disorders.
Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes.
TLDR
A new generation of PPARgamma modulators is being actively developed to activate the receptor more specifically, in a cell and time-dependent manner, in order to induce a specific subset of target genes only and modulate a restricted number of metabolic pathways.
Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription.
TLDR
EDCs may affect endocrine functions by altering steroid hormone metabolism through PXR, and the expression of CYP3A1 mRNA in the liver of rats exposed to phthalic acid or nonylphenol markedly increased compared with that in rats treated with estradiol, bisphenol A, or ethanol as assessed by competitive RT-PCR.
Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
TLDR
Overall, it is believed that the sequence of key events that are relevant to DEHP-induced liver carcinogenesis in rodents involves the following events whereby the combination of the molecular signals and multiple pathways contribute to the formation of tumors.
...
1
2
3
4
5
...